Insulet (NASDAQ:PODD) reported quarterly earnings results on February 18, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.55, beating the consensus estimate of $1.47 by $0.08 per share. Revenue came in at $783.8M, beating the estimate of $768.2M.
Insulet's stock moved following the earnings release. The stock currently trades at $249.10 with a market capitalization of $20.7B.
